ArticleFrontiers in genetics2023

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Qiaorui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.